Resultados de la búsqueda 71-80 of 4553 for targeted supplements

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  6. Hematología - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. ... target dose of ABBV-383. In ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...

  9. Radiología - Ensayos clínicos - Mayo Clinic

    ... target; 6 cycle maximum) over a period of 12 months * Visit the clinic three times for the first week of cycle one, then once a week for the remaining 7 ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... targeted therapies: targeted radiopharmaceutical therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After enrollment, patients will receive one cycle ...